Lazard secures Pfizer healthcare mandate

Pfizer, the US pharmaceuticals giant, has appointed long-standing adviser Lazard to explore strategic options for its consumer healthcare business, valued by one analyst at $10bn (€8.4bn).

A spokesman for Lazard confirmed the bank had been appointed. Pfizer was not immediately available for comment.

WSJ Logo
Ray Dalio Sells Last Stake in Bridgewater, the Hedge Fund That Made Him a BillionaireExternal link

Ray Dalio Sells Last Stake in Bridgewater, the Hedge Fund That Made Him a Billionaire